Page last updated: 2024-10-24

galactose transmembrane transport

Definition

Target type: biologicalprocess

The process in which galactose is transported across a lipid bilayer, from one side of a membrane to the other. D-galactose is widely distributed in combined form in plants, animals and microorganisms as a constituent of oligo- and polysaccharides; it also occurs in galactolipids and as its glucoside in lactose and melibiose. [GOC:ai]

Galactose transmembrane transport is a crucial process for the uptake of galactose, a simple sugar, into cells. It is essential for various metabolic pathways, including the production of lactose, a primary energy source for newborns, and the synthesis of glycoproteins and glycolipids, which play important roles in cell signaling and recognition. This transport process is facilitated by a family of membrane proteins known as sugar transporters, specifically the galactose transporter (GLUT) family.

The mechanism of galactose transmembrane transport involves the following steps:

1. **Binding of galactose to the transporter:** The galactose molecule binds to a specific site on the transporter protein, located on the extracellular side of the cell membrane.

2. **Conformational change in the transporter:** Upon galactose binding, the transporter protein undergoes a conformational change, opening up a passage through the membrane.

3. **Translocation of galactose:** The galactose molecule is then translocated across the cell membrane through the open passageway.

4. **Release of galactose into the cytoplasm:** Once inside the cell, the galactose molecule is released from the transporter, which returns to its original conformation, ready to bind another galactose molecule.

The transport process is driven by the concentration gradient of galactose, meaning that galactose moves from an area of high concentration to an area of low concentration. In other words, galactose flows passively down its concentration gradient.

The activity of galactose transporters can be influenced by a number of factors, including:

* **Hormones:** Insulin, for example, can increase the activity of galactose transporters.
* **Blood glucose levels:** When blood glucose levels are low, the activity of galactose transporters may be increased to help provide cells with alternative energy sources.
* **Cell type:** Different cell types may express different types of galactose transporters, or may have varying levels of transporter activity.

Galactose transmembrane transport is an essential process for maintaining normal cellular function. Disruptions in this process can lead to a variety of health problems, including galactosemia, a genetic disorder characterized by the inability to metabolize galactose.
'"

Proteins (3)

ProteinDefinitionTaxonomy
Sodium/glucose cotransporter 1A sodium/glucose cotransporter 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P13866]Homo sapiens (human)
Solute carrier family 2, facilitated glucose transporter member 3A solute carrier family 2, facilitated glucose transporter member 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P11169]Homo sapiens (human)
Solute carrier family 2, facilitated glucose transporter member 2A solute carrier family 2, facilitated glucose transporter member 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P11168]Homo sapiens (human)

Compounds (18)

CompoundDefinitionClassesRoles
phloretindihydrochalconesantineoplastic agent;
plant metabolite
phlorhizinaryl beta-D-glucoside;
dihydrochalcones;
monosaccharide derivative
antioxidant;
plant metabolite
vexibinolsophoraflavanone G : A tetrahydroxyflavanone having a structure of naringenin bearing an additional hydroxyl substituent at position 2' as well as a (2R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl (lavandulyl) substituent at position 8'.

vexibinol: flavanol from Sophora; structure in first source; RN given refers to (S-(R*,S*))-isomer
(2S)-flavan-4-one;
4'-hydroxyflavanones;
tetrahydroxyflavanone
antimalarial;
antimicrobial agent;
antioxidant;
plant metabolite
2',4',6'-Trihydroxydihydrochalconechalcones
quercetin7-hydroxyflavonol;
pentahydroxyflavone
antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger
myricetin7-hydroxyflavonol;
hexahydroxyflavone
antineoplastic agent;
antioxidant;
cyclooxygenase 1 inhibitor;
food component;
geroprotector;
hypoglycemic agent;
plant metabolite
cytochalasin bcytochalasin B : An organic heterotricyclic compound, that is a mycotoxin which is cell permeable an an inhibitor of cytoplasmic division by blocking the formation of contractile microfilaments.

Cytochalasin B: A cytotoxic member of the CYTOCHALASINS.
cytochalasin;
lactam;
lactone;
organic heterotricyclic compound
actin polymerisation inhibitor;
metabolite;
mycotoxin;
platelet aggregation inhibitor
2',4',6'-trihydroxychalconepinocembrin chalcone : A member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 2', 4' and 6' respectively.

pinocembrin chalcone: isolated from Helichrysum trilineatum; structure in first source
chalconesantifungal agent;
plant metabolite
sergliflozin etabonatesergliflozin: a hypoglycemic agent that inhibits SGLT2 sodium-glucose transporter; structure in first sourceglycoside
remogliflozin etabonateremogliflozin etabonate: orally administered hypoglycemic agent; structure in first sourceglycoside
dapagliflozinaromatic ether;
C-glycosyl compound;
monochlorobenzenes
hypoglycemic agent;
sodium-glucose transport protein subtype 2 inhibitor
ipragliflozinglycoside
empagliflozinaromatic ether;
C-glycosyl compound;
monochlorobenzenes;
tetrahydrofuryl ether
hypoglycemic agent;
sodium-glucose transport protein subtype 2 inhibitor
1,5-anhydro-1-(5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl)-1-thioglucitoldiarylmethane
nothofaginnothofagin: a dihydrochalcone
canagliflozincanagliflozin hydrate : A hydrate that is the hemihydrate form of canagliflozin. Used for treatment of type II diabetes via inhibition of sodium-glucose transport protein subtype 2.C-glycosyl compound;
organofluorine compound;
thiophenes
hypoglycemic agent;
sodium-glucose transport protein subtype 2 inhibitor
pf 04971729ertugliflozin: structure in first sourcediarylmethane
deberza2-benzofurans